# Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer

> **NCT00058201** · PHASE3 · COMPLETED · sponsor: **Royal Liverpool University Hospital** · enrollment: 1030 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** leucovorin calcium
- **OTHER:** clinical observation

## Key facts

- **NCT ID:** NCT00058201
- **Lead sponsor:** Royal Liverpool University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2008-04
- **Final completion:** 2010-09
- **Target enrollment:** 1030 (ESTIMATED)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00058201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00058201, "Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00058201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*